Mylan Institutional Drug Patent Portfolio
Mylan Institutional owns 1 orange book drug protected by 2 US patents Given below is the list of Mylan Institutional's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5866591 | Stable formulations of remifentanil | 10 Mar, 2018 | Expired |
| US5866591 | Stable formulations of remifentanil | 10 Sep, 2017 | Expired |
Mylan Institutional's Family Patents
Recently granted tentative Approvals to Mylan Institutional
These tentative approvals reflect continued regulatory progress across both innovative and generic submissions related to Mylan Institutional's portfolio.
Innovator tentative approvals
| Drug Name | Active Ingredient | Submission Type | Submission Category | Submission Date |
|---|---|---|---|---|
| Abacavir And Lamivudine | Abacavir;lamivudine |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 3 - New Dosage Form | 23 Oct, 2014 |
| Lamivudine; Zidovudine; Efavirenz | Lamivudine;zidovudine;efavirenz |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 4 - New Combination | 04 Sep, 2014 |
| Lamivudine; Zidovudine | Lamivudine; Zidovudine |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 5 - New Formulation or New Manufacturer | 04 Feb, 2014 |
Generic tentative approvals
| Drug Name | Active Ingredient | Submission Type | Submission Category | Submission Date |
|---|---|---|---|---|
| Sumatriptan Succinate | Sumatriptan Succinate |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 24 Jan, 2007 |
| Fexofenadine Hcl; Pseudoephedrine Hcl | Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 30 Apr, 2004 |
| Quinapril Hydrochloride | Quinapril Hydrochloride |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 24 May, 2002 |
Explore deeper patents analysis
Mylan Institutional Drug List
Given below is the complete list of Mylan Institutional's drugs and the patents protecting them.
1. Ultiva
Ultiva is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5866591
(Pediatric)
| Stable formulations of remifentanil |
10 Mar, 2018
(7 years ago)
| Expired |
| US5866591 | Stable formulations of remifentanil |
10 Sep, 2017
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ultiva's drug page